News

GenVec, a bio-pharmaceutical company developing novel gene-based therapeutic drugs and vaccines, has received a phase 2 Small Business Innovation and Research (SBIR) grant from the National Institute of

AstraZeneca, a manufacturer of prescription pharmaceuticals, biologics and vaccines, has opened its new office in Azerbaijan to expand its market presence – reported Fineko/abc.az. According to the news

Piramal Life Sciences has completed the phase-I clinical trials of a new drug for the treatment of diabetes – reported IANS. The company said in a statement that

Beth R Jacobson has filed a suit against Celgene. The lawsuit claims of misappropriation of an idea and unjust enrichment regarding the company’s sale of thalidomide (Thalomid and

AVI BioPharma has revealed the results and scientific findings of its phase 1 clinical trial assessing the proof of concept and safety of AVI-4658 in patients with Duchenne

The FDA has accepted Labopharm’s response regarding its novel formulation of the antidepressant – trazodone as complete, and designated it as a Class 2 resubmission. Labopharm has received

Alvine has initiated patient enrollment in a phase 2a, randomized, double-blind, placebo-controlled study, to assess the safety and efficacy of ALV003 for the treatment of celiac disease. The

GlaxoSmithKline (GSK) has issued a statement in response to the FDA’s Early Communication about the safety review of orlistat. The company said that the FDA is reviewing data

APP Pharmaceuticals (APP) has received approval from the FDA to market Penicillin G Potassium for Injection, USP, in two dosage strengths. Penicillin G is used to treat a